Wacker Biotech
Jena, DE · Amsterdam, NL · San Diego, CA
Compare Recombinant Proteins CDMOs in Europe
Compare Recombinant Proteins CDMOs in Germany
Compare Plasmid DNA CDMOs in Europe
Compare Plasmid DNA CDMOs in Germany
Compare mRNA/LNP CDMOs in Europe
Compare mRNA/LNP CDMOs in Germany
Program data pending ClinicalTrials.gov matching
· Last scored 2026-11-02
82.9
Signal Score
✓ FDA Inspections (1)
○ Clinical Trials
○ SEC Filings
○ Press
✓ EMA GMP (13)
○ MHRA GMP
✓ HC GMP (3)
Quick Facts: Wacker Biotech
- Signal Score
- 82.9/100 (as of 2026-11-02)
- Quality Compliance
- 100.0/100 — Clean EMA record: 13 active GMP certificates (no deductions)
- Headquarters
- Jena, DE · Amsterdam, NL · San Diego, CA
- Website
- https://wacker.com
- Modalities
- Recombinant Protein, Plasmid DNA, mRNA, Microbial Fermentation
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Wacker Biotech
CureVac mRNA manufacturing partner.
Signal Score & Pillar Breakdown
Quality Compliance
100.0
Clean EMA record: 13 active GMP certificates (no deductions)
Sources: FDA Data Dashboard, EMA EudraGMDP
Clean EMA record: 13 active GMP certificates (no deductions)
FDA Inspections1 on record
Warning Letters0
Last InspectionVoluntary Action Indicated (VAI) (2023-12-07)
EMA GMP Certificates13 on record
Most Recent HC OutcomeCompliant · 2023-06-22
HC Attribution3 company-level
Source: Health Canada Drug and Health Product Inspections Database. Ratings shown in Health Canada's own vocabulary; not equivalent to FDA classifications. Company-level records are attributed by the regulator's published establishment name, not by a verified site identifier. Contains information licensed under the Open Government Licence – Canada.
Clean EMA record: 13 active GMP certificates (no deductions)
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesRecombinant Protein, Plasmid DNA, mRNA, Microbial Fermentation
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Scored from ClinicalTrials.gov and FDA records; SEC EDGAR and press items are shown as company signals, not scored. No unverified estimates shown.
Financial Stability
68.0
Parent company: Wacker Chemie AG (WCH.DE)
Financial assessment: 68.0/100
Source: company profile (public/private status, parent company)
Profile-based financial assessment
SEC FilingsPrivate company
Parent company: Wacker Chemie AG (WCH.DE)
Financial assessment: 68.0/100
Capacity
68.0
3 manufacturing sites
Broad modality coverage (4 modalities)
Sites: Jena, Germany, Amsterdam, Netherlands, San Diego, CA
Source: company profiles (manufacturing sites, modality breadth)
3 manufacturing sites
3 manufacturing sites
Broad modality coverage (4 modalities)
Wacker Biotech FDA Inspection History
2023-12
NAI
VAI
OAI
| Date | Site | Type | 483 citations posted | Classification |
|---|---|---|---|---|
| 2023-12-07 |
Wacker Biotech GmbH
Halle (Saale)
Company-level
|
Drug Quality Assurance | Not posted | Voluntary Action Indicated (VAI) |
Source: FDA Data Dashboard · Retrieved Nov 21, 2026
Wacker Biotech EMA GMP Compliance 13 certificates
2025-11
2025-11
2025-11
2025-11
2025-11
2025-11
2025-06
2025-01
2025-01
2025-01
2024-09
2024-09
2024-09
Compliant
Non-Compliant
| Certificate | Site | Country | Inspection Date | Status |
|---|---|---|---|---|
| DE_SN_01_GMP_2025_0064 | Wacker Chemie AG | Germany | 2025-11-04 | COMPLIANT |
| DE_SN_01_GMP_2025_0066 | Wacker Chemie AG | Germany | 2025-11-04 | COMPLIANT |
| DE_SN_01_GMP_2025_0063 | Wacker Chemie AG | Germany | 2025-11-04 | COMPLIANT |
| DE_SN_01_GMP_2025_0062 | Wacker Chemie AG | Germany | 2025-11-04 | COMPLIANT |
| DE_SN_01_GMP_2025_0067 | Wacker Chemie AG | Germany | 2025-11-04 | COMPLIANT |
| DE_SN_01_GMP_2025_0065 | Wacker Chemie AG | Germany | 2025-11-04 | COMPLIANT |
| DE_TH_01H_GMP_2025_0038 | Wacker Biotech GmbH | Germany | 2025-06-05 | COMPLIANT |
| NL/API 25/2054513 | Wacker Biotech B.V. | Netherlands | 2025-01-16 | COMPLIANT |
| NL/H 25/2054513B2 | Wacker Biotech B.V. | Netherlands | 2025-01-16 | COMPLIANT |
| NL/H 25/2054513 | Wacker Biotech B.V. | Netherlands | 2025-01-16 | COMPLIANT |
| DE_ST_01_GMP_2025_0017 | Wacker Biotech GmbH | Germany | 2024-09-18 | COMPLIANT |
| DE_ST_01_GMP_2025_0018 | Wacker Biotech GmbH | Germany | 2024-09-18 | COMPLIANT |
| DE_ST_01_GMP_2025_0019 | Wacker Biotech GmbH | Germany | 2024-09-18 | COMPLIANT |
Source: EMA EudraGMDP · Retrieved Nov 21, 2026
Japan-accredited overseas site (PMDA)
biologics · 1 site
- Amsterdam, Netherlands · Wacker Biotech B.V. — biologics · valid to Oct 3, 2031
PMDA accreditation of a foreign manufacturing site is recognition within Japan's regulatory system, not an inspection outcome. PMDA's list covers only manufacturing sites outside Japan, so a company's plants in Japan are not on it. Source: PMDA, list of accredited/registered foreign manufacturers (as of Oct 16, 2026), Public Data License 1.0 (terms)
Hiring Activity Beta
From public job postings on the parent company's careers board, as of Nov 20, 2026. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No open roles were listed at this business's sites on Nov 20, 2026.
Coverage: read from the parent company's careers board and kept only postings at this business's sites (Wacker Biotech sites (Jena, Halle, Amsterdam, San Diego)). Roles outside those sites are left out, and some of this unit's roles may be missed.
Function groups come mainly from job titles (about 84% match a hand check), and modality words from titles only, so both are approximate.
Source:
jobs.wacker.com
· Checked Nov 20, 2026 · Tracking since Oct 26, 2026
Frequently Asked Questions About Wacker Biotech
How many FDA inspections does Wacker Biotech have on record?
CDMO Signal tracks 1 FDA inspection for Wacker Biotech, sourced from the FDA inspection database. See the full inspection history above.
Has Wacker Biotech received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Wacker Biotech.
Does Wacker Biotech hold EMA or MHRA GMP certificates?
CDMO Signal tracks 13 EMA GMP certificates for Wacker Biotech.
What is Wacker Biotech's CDMO Signal Score?
Wacker Biotech has a Signal Score of 83/100, based on quality, operations, financial stability, and capacity data.
Evaluating Wacker Biotech for a manufacturing program?
Use the free AI matchmaker to compare Wacker Biotech against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
FUJIFILM Diosynth Biotechnologies
Research Triangle, NC · Holly Springs, NC · Hillerod, DK
Signal Score: 86.7
AAV, mRNA/LNP, Biologics, mRNA, Microbial Fermentation, Recombinant Protein
Catalent
Tampa, FL
Signal Score: 76.1
Monoclonal Antibody, Recombinant Protein, ADC, AAV, mRNA, Plasmid DNA, Fill-Finish
Lonza
Basel, Switzerland
Signal Score: 72.8
AAV, Lentiviral, Cell Therapy, mRNA, ADC, Monoclonal Antibody, Recombinant Protein, Microbial Fermentation, Small Molecule API, High-Potency APIs, Oral Solid Dose
KBI Biopharma
Durham, NC · Boulder, CO
Signal Score: 84.1
Monoclonal Antibody, Recombinant Protein, AAV (analytical only), Plasmid DNA
AGC Biologics
Longmont, CO · Milan, IT · Copenhagen, DK · Chiba, JP
Signal Score: 79.9
CAR-T, Cell Therapy, AAV, Lentiviral, ADC, Monoclonal Antibody, Recombinant Protein, Microbial Fermentation
Compare Wacker Biotech with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.